Balancing Speed and Stamina in CLL Treatment | Blood Cancers Today
Future CLL treatment will center on choosing between indefinite or time-defined therapy, says Ryan W. Jacobs, MD, highlighting a shift from past chemoimmunotherapy limits.
Related Articles
Researchers Evaluate Novel Circular RNA Vaccine for Lung Cancer
A novel circular RNA vaccine may be a “promising strategy for the clinical treatment of lung cancer,” according to research presented at AACR 2025.
How a Team Integrated Nurse Navigators Into a Virtual Prostate Cancer Care Clinic | Cancer Nursing Today
Integrating a genitourinary oncology nurse navigator (ONN) role into a virtual prostate cancer care team showed multiple benefits for patients and multidisciplinary teams.
Eating More Fiber May Help Lower PFAS Levels in Your Body, Study Finds
New research suggests that eating more fiber can help lower PFAS levels in your body.
You Don’t Need Meat To Build Muscle, Scientists Say
Both plant-based and animal-based diets supported equal muscle growth during resistance training when protein intake was adequate. A new study examined how muscle protein synthesis…
Anti-aging: Vitamin D shaves three years off your biological age
Taking a vitamin D supplement – or getting enough of the compound naturally – can knock three years off your biological aging, according to the…
Biden officials knew about, downplayed risks from COVID-19 vaccines,…
Top health officials were aware of and actively took steps to “delay warning the public” for months in 2021 about the potential risks of patients…
FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation | CNN
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the…
ChatGPT CEO Just Bet $180 Million That Aging Can Be Reversed — He Wants to Add 10 Healthy Years to Your Life (Through Cellular Reprogramming And Autophagy)
Is age just a number — or soon-to-be a reversible condition? That’s what Sam Altman, OpenAI’s boundary-pushing CEO, is betting $180 million on.
Quality of content reporting on two major oncology media websites: OncLive and Targeted Oncology – PubMed
Our study demonstrates low quality and potentially biased reporting of oncology news on OncLive and TargetedOnc. Careful safeguards, oversight and reporting of relevant FCOI are…
Qualtrics Survey | Qualtrics Experience Management
The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.
